Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Dexcom Inc shares valued at $24,756 were sold by Heller Bridgette P on Mar 17 ’25. At $70.33 per share, Heller Bridgette P sold 352 shares. The insider’s holdings dropped to 22,997 shares worth approximately $1.95 million following the completion of this transaction.
Also, Heller Bridgette P purchased 352 shares, netting a total of over 24,756 in proceeds.
Before that, Leach Jacob Steven had sold 14,076 shares from its account. In a trade valued at $990,670, the EVP, Chief Operating Officer traded Dexcom Inc shares for $70.38 each. Upon closing the transaction, the insider’s holdings decreased to 14,076 shares, worth approximately $26.59 million.
As published in their initiating research note from Mizuho on April 10, 2025, Dexcom Inc [DXCM] has been an Outperform and the price target has been revised to $85. Analysts at Redburn Atlantic upgraded the stock from ‘”a Neutral”‘ to ‘”a Buy”‘ outlook in a report released in early February. As of January 16, 2025, Robert W. Baird has increased its “Neutral” rating to a “an Outperform” for DXCM. Earlier on July 26, 2024, Robert W. Baird downgraded its rating. Their new recommendation was “a Neutral” for DXCM stock which previously was a “an Outperform”.
Analyzing DXCM Stock Performance
During the last five days, there has been a drop of approximately -0.98%. Over the course of the year, Dexcom Inc shares have jumped approximately 9.08%. Shares of the company reached a 52-week high of $93.25 on 02/18/25 and a 52-week low of $57.52 on 04/04/25.
Support And Resistance Levels for Dexcom Inc (DXCM)
According to the 24-hour chart, there is a support level at 84.30, which, if violated, would cause prices to drop to 83.78. In the upper region, resistance lies at 85.33. The next price resistance is at 85.84. RSI (Relative Strength Index) is 62.93 on the 14-day chart, showing neutral technical sentiment.
